Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF 10F
NM
-
Bortezomib
Proteasome
Proteasome
7487.074
uM
0.14698
0.69853
-0.9095 -0.9810 0.6967 0.8500
0.9984
1.4197
HCC1954
HER2amp
Basal A
Fascaplysin
CDK4
CDK
7456.084
uM
0.31254
0.47190
-0.8694 -0.8430 2.3979 0.6118
0.9984
1.9822
HCC70
TNBC
Basal A
MG-132
Proteasome
Proteasome
12400.17
uM
0.07474
0.11640
-0.9170 -0.9300 2.3720 0.9712
0.9984
1.1992
HCC3153
TNBC
Basal A
TCS 2312
CHK1
CHK
10577.14
uM
0.51320
0.79217
-0.8743 -0.8700 2.3219 0.5520
0.9984
0.9722
AU565
HER2amp
Luminal
Docetaxel
TUBB
TUBB
9146.002
uM
0.00498
0.00636
-0.6733 -0.6767 3.4844 0.9399
0.9984
1.2611
MDA-MB-157
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7498.074
uM
0.02939
0.04654
-0.9813 -0.9617 2.3346 1.2452
0.9984
1.0877
SK-BR-3
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9760.131
uM
2.20840
3.62970
-0.9282 -0.9079 2.0834 0.6047
0.9984
0.9878
MDA-MB-157
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7498.074
uM
0.02939
0.04654
-0.9813 -0.9617 2.3346 1.2452
0.9984
1.0877
HCC1187
TNBC
Basal A
Taxol
TUBB
TUBB
9244.002
uM
0.00722
0.00898
-0.9968 -0.9950 5.0000 1.2989
0.9984
0.5206
HMT-3522 T4-2
Unknown
Unknown
Taxol
TUBB
TUBB
10147.002
uM
0.00858
0.00955
-0.3666 -0.3520 4.9998 0.8604
0.9984
1.9641
MCF 10F
NM
-
Bortezomib
Proteasome
Proteasome
7487.074
uM
0.14698
0.69853
-0.9095 -0.9810 0.6967 0.8500
0.9984
1.4197
HCC38
TNBC
Basal B
Etoposide
TOP2
TOP
7469.074
uM
0.38626
0.67303
-0.5694 -0.5634 1.3590 0.7416
0.9984
1.9843
HCC1937
TNBC
Basal A
Vorinostat
HDAC
HDAC
7453.065
uM
195.40680
353.64710
-0.3863 -0.4217 1.0310 0.4348
0.9984
1.6649
AU565
HER2amp
Luminal
Imatinib
ABL/KIT/PDGFR
nRTK
5901.091
uM
19.04840
28.45990
-0.8741 -0.8850 2.5375 0.4460
0.9984
1.9229
MCF 10A
NM
Basal B
Trichostatin A
HDAC
HDAC
7485.065
uM
28.32790
56.52840
-0.4782 -0.4940 0.9945 0.5158
0.9984
3.5869
SUM52PE
HR+
Luminal
NSC 663284
CDC25
CDC
10695.152
uM
2.59830
4.10010
-0.9330 -0.9389 2.3173 0.5662
0.9985
1.2495
184A1
NM
Basal
Ixabepilone
TUBB
TUBB
5894.095
uM
0.46640
0.69919
-0.9010 -0.8976 2.5388 0.6159
0.9985
1.7133
UACC-812
HER2amp
Luminal
Geldanamycin
HSP90
HSP90
10150.012
uM
0.02042
0.02445
-0.7512 -0.7308 4.9997 1.1335
0.9985
0.4611
MCF12A
NM
Basal B
Imatinib
ABL/KIT/PDGFR
nRTK
7489.09
uM
31.0410
41.980
-0.8584 -0.8585 3.3109 0.3463
0.9985
1.9790
SUM149PT
TNBC
Basal B
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14284.189
uM
0.36137
0.67697
-0.9692 -0.9604 1.7075 0.7034
0.9985
1.3873
MCF 10A
NM
Basal B
Erlotinib
EGFR
ErbB
7485.092
uM
2.71020
1.84470
0.2084 0.1437 0.8807 0.2027
0.9985
3.6408
SUM149PT
TNBC
Basal B
IKK16
IKK
NFKB
7530.093
uM
1.87280
3.05350
-0.7995 -0.8199 1.9856 0.4273
0.9985
2.1548
MDA-MB-231
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7504.074
uM
0.09433
0.12339
-0.8488 -0.8128 3.5944 0.9992
0.9985
1.8962
SUM149PT
TNBC
Basal B
Olomoucine II
CDK1
CDK
10819.147
uM
7.07230
8.84820
-0.7606 -0.7610 4.1293 0.3660
0.9985
2.1652
HCC1419
HER2amp
Luminal
Epirubicin
TOP2
TOP
7821.017
uM
0.78388
0.97271
-1.0000 -0.9710 5.0000 0.7996
0.9985
0.3792